Quoin Pharmaceuticals (QNRX) Price to Book (2018 - 2026)

Quoin Pharmaceuticals has disclosed Price to Book across 9 years of filings, most recently posting 0.12 for Q2 2026.

• In Q2 2026, Price to Book rose 63.85% year-over-year to 0.12; the TTM figure through Jun 2026 stood at 0.12 (up 63.85% YoY), while the FY2025 annual figure was 0.04, down 89.88% from the prior year.
• Price to Book came in at 0.12 for Q2 2026 at Quoin Pharmaceuticals, up from 0.07 in the prior quarter.
• In the past five years, Price to Book ranged from a high of 6.5 in Q4 2022 to a low of 214.09 in Q1 2022.
• Average Price to Book over 5 years is 11.08, with a median of 0.32 recorded in 2024.
• Year-over-year, Price to Book tumbled 121.75% in 2025 and soared 174.55% in 2026.
• Over 5 years, Price to Book stood at 6.5 in 2022, then slumped by 84.66% to 1.0 in 2023, then tumbled by 61.22% to 0.39 in 2024, then slumped by 89.88% to 0.04 in 2025, then jumped by 196.77% to 0.12 in 2026.
• Per Business Quant data, the three most recent Price to Book figures were 0.12 in Q2 2026, 0.07 in Q1 2026, and 0.04 in Q4 2025.